ChemoCentryx (CCXI) Short Interest Ratio & Short Volume → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free CCXI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis ChemoCentryx Short Interest DataCurrent Short Volume7,610,000 sharesPrevious Short Volume7,270,000 sharesChange Vs. Previous Month+4.68%Dollar Volume Sold Short$393.13 millionShort Interest Ratio / Days to Cover3.2Last Record DateSeptember 30, 2022Outstanding Shares71,356,000 sharesFloat Size67,400,000 sharesShort Percent of Float11.29%Today's Trading Volume113 sharesAverage Trading Volume1,681,906 sharesToday's Volume Vs. Average0% Short Selling ChemoCentryx ? Sign up to receive the latest short interest report for ChemoCentryx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCCXI Short Interest Over TimeCCXI Days to Cover Over TimeCCXI Percentage of Float Shorted Over Time Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. ChemoCentryx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/30/20227,610,000 shares $393.13 million +4.7%11.3%3.2 $51.66 9/15/20227,270,000 shares $375.13 million +5.1%10.8%3.1 $51.60 8/31/20226,920,000 shares $352.78 million +0.1%11.9%3 $50.98 8/15/20226,910,000 shares $351.10 million +6.1%11.9%3.1 $50.81 7/31/20226,510,000 shares $153.77 million -0.8%11.2%3.2 $23.62 7/15/20226,560,000 shares $150.49 million +3.1%11.3%4.8 $22.94 Get the Latest News and Ratings for CCXI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ChemoCentryx and its competitors with MarketBeat's FREE daily newsletter. 6/30/20226,360,000 shares $157.60 million +12.8%11.0%4.4 $24.78 6/15/20225,640,000 shares $136.38 million +12.1%18.5%3.9 $24.18 5/31/20225,030,000 shares $112.02 million -12.2%8.7%3.7 $22.27 5/15/20225,730,000 shares $109.84 million -4.5%9.9%3.9 $19.17 4/30/20226,000,000 shares $110.76 million -9.2%10.4%4.4 $18.46 4/15/20226,610,000 shares $142.38 million -8.5%11.4%5.4 $21.54 3/31/20227,220,000 shares $181.01 million +6.3%12.6%5.5 $25.07 3/15/20226,790,000 shares $155.56 million +64.0%11.8%5.3 $22.91 2/28/20224,140,000 shares $125.61 million -6.8%7.2%2.9 $30.34 2/15/20224,440,000 shares $140.26 million -10.5%7.8%3.4 $31.59 1/31/20224,960,000 shares $133.37 million -16.5%8.7%3.5 $26.89 1/15/20225,940,000 shares $193.05 million +4.6%N/A4 $32.50 12/31/20215,680,000 shares $206.81 million +1.6%9.9%2.4 $36.41 12/15/20215,590,000 shares $194.25 million +13.6%9.8%1.1 $34.75 11/30/20214,920,000 shares $178.50 million -18.5%8.6%1 $36.28 11/15/20216,040,000 shares $240.15 million -2.3%10.6%1.3 $39.76 10/29/20216,180,000 shares $215.13 million +12.8%10.8%1.3 $34.81 10/15/20215,480,000 shares $188.90 million +40.9%9.6%1.2 $34.47 9/30/20213,890,000 shares $66.52 million +4.3%7.3%0.9 $17.10 9/15/20213,730,000 shares $59.61 million -16.6%7.0%1.8 $15.98 8/31/20214,470,000 shares $70.67 million -3.3%8.4%1.7 $15.81 8/13/20214,620,000 shares $64.68 million -7.4%8.7%1.6 $14.00 7/30/20214,990,000 shares $73.75 million -11.4%9.4%1.5 $14.78 7/15/20215,630,000 shares $87.21 million +4.5%10.6%1.3 $15.49 6/30/20215,390,000 shares $72.17 million +34.8%10.1%1.3 $13.39 6/15/20214,000,000 shares $51.24 million +27.4%7.5%1.2 $12.81 5/28/20213,140,000 shares $31.87 million +35.9%5.9%1.2 $10.15 5/14/20212,310,000 shares $23.03 million -34.6%4.3%1 $9.97 4/30/20213,530,000 shares $158.85 million -0.8%6.6%1.8 $45.00 4/15/20213,560,000 shares $168.53 million -2.5%6.7%7.5 $47.34 3/31/20213,650,000 shares $181.95 million -2.7%6.8%7.5 $49.85 3/15/20213,750,000 shares $216.23 million +2.7%7.1%7.4 $57.66 2/26/20213,650,000 shares $240.43 million +13.0%6.9%7 $65.87 2/12/20213,230,000 shares $200.66 million -31.1%6.1%6.3 $62.13The “Perfect Storm” for Gold (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! CCXI Short Interest - Frequently Asked Questions What is ChemoCentryx's current short interest? Short interest is the volume of ChemoCentryx shares that have been sold short but have not yet been closed out or covered. As of September 30th, investors have sold 7,610,000 shares of CCXI short. 11.29% of ChemoCentryx's shares are currently sold short. Learn More on ChemoCentryx's current short interest. What is a good short interest ratio for ChemoCentryx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CCXI shares currently have a short interest ratio of 3.0. Learn More on ChemoCentryx's short interest ratio. What is a good short interest percentage for ChemoCentryx? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.29% of ChemoCentryx's floating shares are currently sold short. Is ChemoCentryx's short interest increasing or decreasing? ChemoCentryx saw a increase in short interest in September. As of September 30th, there was short interest totaling 7,610,000 shares, an increase of 4.7% from the previous total of 7,270,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ChemoCentryx's float size? ChemoCentryx currently has issued a total of 71,356,000 shares. Some of ChemoCentryx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ChemoCentryx currently has a public float of 67,400,000 shares. How does ChemoCentryx's short interest compare to its competitors? 11.29% of ChemoCentryx's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to ChemoCentryx: Alkermes plc (8.48%), Amicus Therapeutics, Inc. (11.00%), Madrigal Pharmaceuticals, Inc. (16.88%), Geron Co. (8.53%), Dynavax Technologies Co. (13.73%), Ligand Pharmaceuticals Incorporated (4.05%), Ionis Pharmaceuticals, Inc. (7.11%), Ironwood Pharmaceuticals, Inc. (14.48%), MannKind Co. (13.21%), Aurinia Pharmaceuticals Inc. (9.57%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.27 billion), Charter Communications, Inc. ($2.66 billion), TC Energy Co. ($2.53 billion), Chesapeake Energy Co. ($1.86 billion), Coinbase Global, Inc. ($1.83 billion), Lucid Group, Inc. ($1.78 billion), T. Rowe Price Group, Inc. ($1.77 billion), Rivian Automotive, Inc. ($1.69 billion), Zoom Video Communications, Inc. ($1.35 billion), and Williams-Sonoma, Inc. ($1.35 billion). View all of the most shorted stocks. What does it mean to sell short ChemoCentryx stock? Short selling CCXI is an investing strategy that aims to generate trading profit from ChemoCentryx as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ChemoCentryx? A short squeeze for ChemoCentryx occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CCXI, which in turn drives the price of the stock up even further. How often is ChemoCentryx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CCXI, twice per month. The most recent reporting period available is September, 30 2022. More Short Interest Resources from MarketBeat Related Companies: ALKS Short Interest FOLD Short Interest MDGL Short Interest GERN Short Interest DVAX Short Interest LGND Short Interest IONS Short Interest IRWD Short Interest MNKD Short Interest AUPH Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CCXI) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHow Biden has already won 2024Porter & CompanyUrgent alert: open this for a huge profit potentialTimothy Sykes